Legal & General Group
LUNG icon

Legal & General Group’s Pulmonx LUNG Stock Holding History

Legal & General Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,166
Closed -$4.07K – 3481
2026
Q1 		$4.07K Sell
3,166
-438
-12% -$724 ﹤0.01% 3310
2025
Q4 		$7.96K Sell
3,604
-397
-10% -$746 ﹤0.01% 3290
2025
Q3 		$6.48K Hold
4,001
– – ﹤0.01% 3348
2025
Q2 		$10.4K Hold
4,001
– – ﹤0.01% 3280
2025
Q1 		$26.9K Sell
4,001
-43
-1% -$304 ﹤0.01% 2841
2024
Q4 		$27.5K Hold
4,044
– – ﹤0.01% 2920
2024
Q3 		$33.5K Sell
4,044
-99
-2% -$716 ﹤0.01% 2865
2024
Q2 		$26.3K Sell
4,143
-20,641
-83% -$159K ﹤0.01% 2917
2024
Q1 		$230K Sell
24,784
-1,163
-4% -$13.6K ﹤0.01% 2655
2023
Q4 		$331K Sell
25,947
-5,458
-17% -$56.9K ﹤0.01% 2597
2023
Q3 		$324K Sell
31,405
-223
-0.7% -$2.58K ﹤0.01% 2602
2023
Q2 		$415K Buy
31,628
+12,357
+64% +$151K ﹤0.01% 2522
2023
Q1 		$215K Buy
19,271
+7,293
+61% +$72K ﹤0.01% 2564
2022
Q4 		$101K Sell
11,978
-322
-3% -$3.06K ﹤0.01% 2816
2022
Q3 		$205K Sell
12,300
-3,929
-24% -$72.3K ﹤0.01% 2622
2022
Q2 		$239K Buy
16,229
+8,720
+116% +$180K ﹤0.01% 2569
2022
Q1 		$186K Buy
7,509
+5
+0.1% +$129 ﹤0.01% 2695
2021
Q4 		$240K Buy
7,504
+29
+0.4% +$1.06K ﹤0.01% 2647
2021
Q3 		$268K Buy
7,475
+3,702
+98% +$146K ﹤0.01% 2591
2021
Q2 		$166K Buy
3,773
+2,311
+158% +$101K ﹤0.01% 2588
2021
Q1 		$67K Sell
1,462
-67
-4% -$3.84K ﹤0.01% 2738
2020
Q4 		$105K Buy
+1,529
New +$74.9K ﹤0.01% 2577

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Legal & General Group's LUNG Position: Q2 2026 in Review

Legal & General Group sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 3,166 shares — an estimated $4.07K sold.

Legal & General Group first reported a position in LUNG in Q4 2020 and held it in 22 quarters. The position peaked at $415K in Q2 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Legal & General Group reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 3,166 Pulmonx shares in Q2 2026, an estimated $4.07K.
  • Legal & General Group first reported a position in Pulmonx in Q4 2020 and held it in 22 quarters.
  • Legal & General Group's Pulmonx position peaked at $415K in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.